TickerFacts.

Haemonetics Corp (HAE): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2023-04-01 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$260.44M
Year ended 2026-03-28
$291.22M
Trailing 12 months to 2026-06-27
+47.2%
3-year compound annual growth
2009-03-28: $59.98M2010-04-03: $74.36M2011-04-02: $76.79M2012-03-31: $62.12M2013-03-30: $22.89M2014-03-29: $65.88M2015-03-28: $4.96M2016-04-02: $19.46M2017-04-01: $83.60M2018-03-31: $145.55M2019-03-30: $40.32M2020-03-28: $109.46M2021-04-03: $71.77M2022-04-02: $75.75M2023-04-01: $81.73M2024-03-30: $143.63M2025-03-29: $142.45M2026-03-28: $260.44M$260.44M
2009-03-28 Free Cash Flow (USD) 2026-03-28
Period endedFree Cash FlowChange YoYSource filing
2026-03-28$260.44M+82.8%2026-05-20, From 2025-03-30
2025-03-29$142.45M-0.8%2026-05-20, From 2024-03-31
2024-03-30$143.63M+75.7%2026-05-20, From 2023-04-02
2023-04-01$81.73Mn/c2025-05-21, From 2022-04-03
2022-04-02$75.75M+5.6%2024-05-20, From 2021-04-04
2021-04-03$71.77M-34.4%2023-05-22, From 2020-03-29
2020-03-28$109.46M+171.5%2022-05-25, From 2019-03-31
2019-03-30$40.32M-72.3%2021-05-26, From 2018-04-01
2018-03-31$145.55M+74.1%2020-05-20, From 2017-04-02
2017-04-01$83.60M+329.6%2019-05-22, From 2016-04-03
2016-04-02$19.46M+292.5%2018-05-23, From 2015-03-29
2015-03-28$4.96M-92.5%2017-05-24, From 2014-03-30
2014-03-29$65.88M+187.8%2016-06-01, From 2013-03-31
2013-03-30$22.89M-63.2%2015-05-22, From 2012-04-01
2012-03-31$62.12M-19.1%2014-05-22, From 2011-04-03
2011-04-02$76.79M+3.3%2013-05-20, From 2010-04-04
2010-04-03$74.36M+24.0%2012-05-22, From 2009-03-29
2009-03-28$59.98Mn/a2011-05-26, From 2008-03-30

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Haemonetics Corp (HAE)2026-03-28$260.44M+82.8%
Penumbra Inc (PEN)2025-12-31$174.93M+18.8%
Merit Medical Systems Inc (MMSI)2025-12-31$215.66M+16.2%
Integra Lifesciences Holdings Corp (IART)2025-12-31-$31.05Mn/m
Embecta Corp. (EMBC)2025-09-30$182.40M+816.6%
Tandem Diabetes Care Inc (TNDM)2025-12-31-$29.67Mn/m
Inspire Medical Systems, Inc. (INSP)2025-12-31$78.48M-13.9%
Teleflex Inc (TFX)2025-12-31$1.45M-99.3%
Orthofix Medical Inc. (OFIX)2025-12-31-$1.28Mn/m

Compare HAE, PEN, MMSI, IART side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗